Ingenium Pharamceutical
Europe, Bayern, Germany, Martinsried
Description
Ingenium Pharmaceuticals GmbH, founded 1998 as a spin-off from the German Human Genome Project, is a subsidiary of the integrated drug
Investor Profile
Ingenium Pharamceutical has made 1 investments, with 0 in the past 12 months and 100% as lead.
Stage Focus
- Series A (100%)
Country Focus
- Germany (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
